Back
Science

Scientists Research Universal Flu Vaccines for Enhanced, Long-Lasting Protection

View source

Flu's Global Impact

A Widespread Health Challenge

Influenza affects approximately one billion individuals globally each year. Symptoms commonly include fever, fatigue, headaches, and cough, often resulting in incapacity for a week or more. Annually, influenza contributes to 290,000 to 650,000 deaths worldwide.

With one billion individuals affected and up to 650,000 deaths annually, influenza represents a significant global health challenge.

Limitations of Current Seasonal Vaccines

The influenza virus undergoes continuous mutation, which necessitates annual vaccination. Current seasonal flu vaccines are effective in preventing many deaths and severe illnesses. However, their effectiveness typically reaches about 60% and can be lower in years when the vaccine's formulation does not closely match the circulating virus strains.

Nicholas Heaton, a professor at Duke University School of Medicine, notes the necessity of annual flu vaccinations due to the virus's evolving nature.

The Promise of Universal Flu Vaccines

Research efforts are underway globally, including at Professor Heaton's lab, to develop "universal" flu vaccines. These vaccines aim to provide improved, broader, and more enduring protection compared to existing seasonal vaccines. The objective of universal vaccines is to offer protection against a wider range of influenza strains and/or extend the duration of protection from a single dose.